Annual CFI
$34.61 M
+$49.61 M+330.70%
31 December 2023
Summary:
Cartesian Therapeutics annual cash flow from investing activities is currently $34.61 million, with the most recent change of +$49.61 million (+330.70%) on 31 December 2023. During the last 3 years, it has risen by +$35.35 million (+4770.58%). RNAC annual CFI is now at all-time high.RNAC Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$6.20 M
-$4.61 M-290.61%
01 September 2024
Summary:
Cartesian Therapeutics quarterly cash flow from investing activities is currently -$6.20 million, with the most recent change of -$4.61 million (-290.61%) on 01 September 2024. Over the past year, it has dropped by -$6.20 million (-100.00%). RNAC quarterly CFI is now -122.04% below its all-time high of $28.12 million, reached on 31 March 2023.RNAC Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$1.89 M
-$6.20 M-143.90%
01 September 2024
Summary:
Cartesian Therapeutics TTM cash flow from investing activities is currently -$1.89 million, with the most recent change of -$6.20 million (-143.90%) on 01 September 2024. Over the past year, it has dropped by -$35.49 million (-105.63%). RNAC TTM CFI is now -105.46% below its all-time high of $34.61 million, reached on 31 December 2023.RNAC TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RNAC Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +330.7% | -100.0% | -105.6% |
| 3 y3 years | +4770.6% | -244.0% | +93.0% |
| 5 y5 years | +37.0% | -153.8% | -1290.4% |
RNAC Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +301.9% | -122.0% | +79.3% | -105.5% | +93.0% |
| 5 y | 5 years | at high | +301.9% | -122.0% | +79.3% | -105.5% | +93.0% |
| alltime | all time | at high | +256.6% | -122.0% | +79.3% | -105.5% | +94.6% |
Cartesian Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$6.20 M(+290.6%) | -$1.89 M(-143.9%) |
| June 2024 | - | -$1.59 M(+163.6%) | $4.31 M(-26.8%) |
| Mar 2024 | - | -$602.00 K(-109.3%) | $5.88 M(-83.0%) |
| Dec 2023 | $34.61 M(-330.7%) | $6.50 M(>+9900.0%) | $34.61 M(+3.0%) |
| Sept 2023 | - | $0.00(-100.0%) | $33.60 M(+817.1%) |
| June 2023 | - | -$12.00 K(-100.0%) | $3.66 M(+2.4%) |
| Mar 2023 | - | $28.12 M(+412.4%) | $3.58 M(-123.8%) |
| Dec 2022 | -$15.00 M(-12.5%) | - | - |
| Dec 2022 | - | $5.49 M(-118.3%) | -$15.00 M(+39.3%) |
| Sept 2022 | - | -$29.94 M(>+9900.0%) | -$10.77 M(-162.0%) |
| June 2022 | - | -$99.00 K(-101.0%) | $17.37 M(+16.9%) |
| Mar 2022 | - | $9.54 M(-1.8%) | $14.85 M(-186.6%) |
| Dec 2021 | -$17.14 M(+2213.1%) | $9.72 M(-639.5%) | -$17.14 M(-36.6%) |
| Sept 2021 | - | -$1.80 M(-31.1%) | -$27.03 M(+5.9%) |
| June 2021 | - | -$2.62 M(-88.3%) | -$25.51 M(+10.7%) |
| Mar 2021 | - | -$22.45 M(>+9900.0%) | -$23.05 M(+3010.8%) |
| Dec 2020 | -$741.00 K(-423.6%) | -$166.00 K(-42.0%) | -$741.00 K(+26.9%) |
| Sept 2020 | - | -$286.00 K(+85.7%) | -$584.00 K(-105.2%) |
| June 2020 | - | -$154.00 K(+14.1%) | $11.21 M(-30.8%) |
| Mar 2020 | - | -$135.00 K(+1400.0%) | $16.21 M(+6979.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $229.00 K(-99.1%) | -$9000.00(-100.1%) | $229.00 K(-268.4%) |
| Sept 2019 | - | $11.51 M(+137.6%) | -$136.00 K(-97.6%) |
| June 2019 | - | $4.84 M(-130.1%) | -$5.63 M(-168.6%) |
| Mar 2019 | - | -$16.12 M(+4209.9%) | $8.21 M(-67.5%) |
| Dec 2018 | $25.27 M(-1304.6%) | -$374.00 K(-106.2%) | $25.27 M(-20.4%) |
| Sept 2018 | - | $6.02 M(-67.8%) | $31.75 M(+35.9%) |
| June 2018 | - | $18.68 M(+1877.2%) | $23.37 M(+51.9%) |
| Mar 2018 | - | $945.00 K(-84.5%) | $15.38 M(-833.0%) |
| Dec 2017 | -$2.10 M(-90.5%) | $6.11 M(-357.6%) | -$2.10 M(-84.4%) |
| Sept 2017 | - | -$2.37 M(-122.2%) | -$13.41 M(-57.1%) |
| June 2017 | - | $10.70 M(-164.7%) | -$31.25 M(-10.9%) |
| Mar 2017 | - | -$16.53 M(+217.7%) | -$35.08 M(+58.7%) |
| Dec 2016 | -$22.10 M(+372.3%) | -$5.20 M(-74.3%) | -$22.10 M(+11.6%) |
| Sept 2016 | - | -$20.21 M(-394.2%) | -$19.80 M(+2339.0%) |
| June 2016 | - | $6.87 M(-293.2%) | -$812.00 K(-90.0%) |
| Mar 2016 | - | -$3.56 M(+22.2%) | -$8.11 M(+73.3%) |
| Dec 2015 | -$4.68 M(+1961.2%) | -$2.91 M(+139.0%) | -$4.68 M(+164.4%) |
| Sept 2015 | - | -$1.22 M(+183.0%) | -$1.77 M(+220.1%) |
| June 2015 | - | -$430.00 K(+249.6%) | -$553.00 K(+349.6%) |
| Mar 2015 | - | -$123.00 K | -$123.00 K |
| Dec 2014 | -$227.00 K | - | - |
FAQ
- What is Cartesian Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Cartesian Therapeutics?
- What is Cartesian Therapeutics annual CFI year-on-year change?
- What is Cartesian Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Cartesian Therapeutics?
- What is Cartesian Therapeutics quarterly CFI year-on-year change?
- What is Cartesian Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Cartesian Therapeutics?
- What is Cartesian Therapeutics TTM CFI year-on-year change?
What is Cartesian Therapeutics annual cash flow from investing activities?
The current annual CFI of RNAC is $34.61 M
What is the all time high annual CFI for Cartesian Therapeutics?
Cartesian Therapeutics all-time high annual cash flow from investing activities is $34.61 M
What is Cartesian Therapeutics annual CFI year-on-year change?
Over the past year, RNAC annual cash flow from investing activities has changed by +$49.61 M (+330.70%)
What is Cartesian Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of RNAC is -$6.20 M
What is the all time high quarterly CFI for Cartesian Therapeutics?
Cartesian Therapeutics all-time high quarterly cash flow from investing activities is $28.12 M
What is Cartesian Therapeutics quarterly CFI year-on-year change?
Over the past year, RNAC quarterly cash flow from investing activities has changed by -$6.20 M (-100.00%)
What is Cartesian Therapeutics TTM cash flow from investing activities?
The current TTM CFI of RNAC is -$1.89 M
What is the all time high TTM CFI for Cartesian Therapeutics?
Cartesian Therapeutics all-time high TTM cash flow from investing activities is $34.61 M
What is Cartesian Therapeutics TTM CFI year-on-year change?
Over the past year, RNAC TTM cash flow from investing activities has changed by -$35.49 M (-105.63%)